The Pet Treatment Index

COMMERCIAL TRANSPARENCY

Affiliate & Sponsorship Disclosure

The Pet Treatment Index may earn money from some actions readers take through clearly identified links or placements. A commercial relationship can help fund research, data maintenance, corrections, and publication operations. It also creates a conflict that must be disclosed and structurally separated from the editorial conclusion.

Version one of the site does not contain compensated treatment, insurance, pharmacy, provider, or product links. This policy establishes the rules that must be in place before any such link is introduced.

How compensation may work later

Potential revenue relationships may include:

  • a flat affiliate fee;
  • a qualified lead or application fee;
  • a booked-consultation fee;
  • a percentage of an eligible sale;
  • a fixed sponsorship;
  • a provider or market subscription;
  • paid research or a sponsored report;
  • data licensing;
  • or another business-to-business service.

The exact relationship can vary by partner and may change. A public page should not claim a payout amount unless that amount is relevant, current, and supportable.

Where a disclosure will appear

When a page contains a compensated action, a plain-language disclosure will appear before or beside the first such action. It will not be hidden only in the footer, behind a tooltip, or on this policy page.

A typical future disclosure may say:

The Pet Treatment Index may earn compensation if an eligible reader completes an action through some links on this page. Compensation does not change the treatment status, evidence, safety, cost method, or editorial conclusion.

The wording may be made more specific when the relationship requires it. A link may also use a clear label such as “paid partner,” “sponsored,” or “affiliate link” where that improves understanding.

The editorial-commercial firewall

Revenue may change which legitimate action is offered. It may never change a treatment’s regulatory status, evidence label, safety discussion, cost methodology, or editorial conclusion.

That means a partner cannot pay for:

  • FDA-approved, conditionally approved, indexed, investigational, compounded, or other status language;
  • a stronger evidence stage;
  • removal of a warning, limitation, adverse fact, or established alternative;
  • a universal “best” ranking;
  • a fake reviewer or credential;
  • a favorable correction;
  • a guarantee of insurance coverage, treatment result, provider availability, or price;
  • or inclusion in a supposedly independent comparison without disclosure.

How future offers will be selected

A future commercial action may be shown only when:

  • it belongs to the reader’s decision stage;
  • the underlying provider or product category is legitimate;
  • eligibility and geographic limits are understood;
  • the page remains useful without the link;
  • the link does not contradict the editorial conclusion;
  • the disclosure is visible;
  • and a noncommercial fallback remains available when no offer fits.

Examples of stage alignment may include:

  • a planning-ahead insurance reader entering a licensed quote flow;
  • a non-emergency reader learning about an appropriate tele-veterinary consultation where allowed;
  • an owner with a valid prescription using a legitimate pharmacy or retailer;
  • an owner facing specialty care reaching a legitimate provider inquiry;
  • or an emerging-treatment reader subscribing to source-linked updates rather than being sent to a gray-market seller.

A person with an already-existing condition should not be pushed into a new insurance quote as though it will pay the current claim.

Rankings and inclusion are not for sale

A partner does not receive a favorable ranking because it pays more. A sponsor does not become the editorial winner by funding a page.

If the site later publishes a comparison, ranking, or provider list, the public methodology must explain:

  • the criteria;
  • what was verified;
  • what was not verified;
  • how ties and missing data are handled;
  • what disqualifies an option;
  • when the facts were checked;
  • and whether any listed entity has a commercial relationship.

Payment may affect whether a legitimate action is commercially available. It may not secretly determine the evidence or decision criteria.

Sponsored content will be labeled at the top and visually distinguished from independent editorial records.

A sponsor may:

  • fund a clearly labeled report;
  • provide current factual information about its own product or service;
  • identify a source or possible correction;
  • and review its attributed company facts for accuracy.

A sponsor may not:

  • write or approve the independent evidence conclusion;
  • suppress unfavorable primary-source information;
  • claim independent veterinary review that did not occur;
  • disguise advertising as an ordinary Treatment Record;
  • or require removal of a legitimate competitor or alternative.

Free products, access, and other consideration

If the publication receives a free product, service, event access, data access, travel, or another material benefit connected to coverage, the relationship should be disclosed where a reasonable reader would want to know it.

Receiving access does not establish that the product works or that the experience represents typical results.

Insurance boundary

The Pet Treatment Index is not an insurer or insurance producer. Insurance education remains general and source-dated. A future quote or application action must lead into an appropriately licensed partner flow and comply with applicable state and partner requirements.

The site does not bind coverage, negotiate terms, make a personalized policy recommendation, or guarantee a claim.

When affiliate links are introduced in a later phase:

  • they must be generated through one centralized component;
  • they must carry appropriate sponsored link attributes;
  • a disclosure must render automatically;
  • eligibility and state rules must be enforceable;
  • link tracking must be described in the Privacy Policy;
  • automated health checks must not inflate partner click data;
  • suspected-bot classification may affect reporting but must never block or reroute a legitimate visitor differently;
  • and an inactive or unknown offer must fail safely rather than redirect to a guessed destination.

Corrections and commercial pressure

A partner, sponsor, or prospective partner may submit a correction. The same evidence standard applies to everyone. Ending a commercial relationship does not remove accurate editorial coverage. Beginning a relationship does not erase earlier criticism.

Read the Corrections Policy

Questions about a relationship

Send questions through Contact and select Partnership or commercial disclosure. Do not send medical records or ask for a treatment recommendation.